Web4 sep. 2024 · 2024年9月1日，再生组织、器官开发公司Humacyte通过与特殊目的收购公司（SPAC）Alpha Healthcare Acquisition Corp.合并正式在纳斯达克资本市场挂牌交易，股票代码为“HUMA”。 通过此次合并交易，Humacyte获得了1.75亿美元PIPE融资和7000万美元现金收益，共计2.45亿美元。 其PIPE投资者包括Fresenius Medical Care、OrbiMed … Web31 aug. 2024 · DURHAM – Humacyte, which officially merged with the special purpose acquisition company Alpha Healthcare Acquisition Corp. after shareholders of the SPAC …
Should You Invest in Humacyte Before the SPAC Merger?
Web17 feb. 2024 · At closing, Humacyte is expected to have a market capitalization of $1.1 billion. Transaction terms call for a common stock PIPE of approximately $175 million at $10 per share that will close simultaneously with the business combination, as well as up to $100 million held in the SPAC’s trust account, subject to any redemptions. Web5 mrt. 2024 · Shukla’s initial AHAC raised $100 million in an IPO in September, signing on to acquire Humacyte just last month. Recommended His previous SPACs include Constellation Alpha Capital Corp, which... microtech terahertz
Humacyte, Inc. - HUMA SPAC - spacHero.com
WebSPAC SPONSOR HAS TRACK RECORD OF BACKING DISRUPTIVE GROWTH COMPANIES AHAC was founded by Rajiv Shukla, extensive track record in healthcare M&A and equity investments Previous SPAC acquired DermTech (NasdaqCM:DMTK): a disruptive innovator in skin cancer diagnostics DermTech vs standard of care biopsy: … Web17 feb. 2024 · NEW YORK, Feb 17 (Reuters) - Humacyte Inc, a developer of universally implantable bioengineered human tissues and organs, said on Wednesday it has agreed to a deal to go public through a merger... Web11 apr. 2024 · -- Humacyte ha dichiarato martedì di aver completato l'arruolamento in uno studio di fase 3 sull'accesso all'emodialisi. Lo studio valuterà l'efficacia e la sicurezza di Human Acellular Vessel nello... 12 aprile 2024 new shows to watch now